4th Quarter - Termination

KING & SPALDING LLP for DAVITA INC

Firm
Client
Income
$30,000
Expenses
—
Terminated
Dec 31, 2009

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

End-stage renal disease reimbursement and policy, including policies contained in H.R. 3590, The Patient Protection and Affordable Care Act; H.R. 3962, Affordable Health Care for America Act; S. 1796, America's Healthy Future Act of 2009

LobbyistCovered position, as disclosed
JASON S MCKITRICK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3962 (111th), H.R. 3590 (111th), S. 1796 (111th)

Medicare/Medicaid MMM

End-stage renal disease reimbursement and policy, including policies contained in H.R. 3590, The Patient Protection and Affordable Care Act; H.R. 3962, Affordable Health Care for America Act; S. 1796, America's Healthy Future Act of 2009

LobbyistCovered position, as disclosed
JASON S MCKITRICK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1796 (111th), H.R. 3962 (111th), H.R. 3590 (111th)

Insurance INS

End-stage renal disease reimbursement and policy, including policies contained in H.R. 3590, The Patient Protection and Affordable Care Act; H.R. 3962, Affordable Health Care for America Act; S. 1796, America's Healthy Future Act of 2009

LobbyistCovered position, as disclosed
JASON S MCKITRICK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1796 (111th), H.R. 3962 (111th), H.R. 3590 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.